Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.

Hasle H.; Abrahamsson J.; Arola M.; Karow A.; O'Marcaigh A.; Reinhardt D.; Webb DKH.; van Wering E.; Zeller B.; Zwaan CM.; Vyas P.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Myeloid leukemia in children 4 years or older with Down syndrome often lacks GATA1 mutation and cytogenetics and risk of relapse are more akin to sporadic AML.

Hasle H., Abrahamsson J., Arola M., Karow A., O'Marcaigh A., Reinhardt D., Webb DKH., van Wering E., Zeller B., Zwaan CM., Vyas P.

Original publication

DOI

10.1038/sj.leu.2405060

Type

Journal article

Journal

Leukemia

Publication Date

07/2008

Volume

Pages

1428 - 1430

Keywords

Child, Child, Preschool, Chromosome Aberrations, Down Syndrome, GATA1 Transcription Factor, Humans, Leukemia, Myeloid, Acute, Mutation, Recurrence, Risk